Skip to main content

Advertisement

Table 2 Study treatments and outcomes

From: Cost-effectiveness of the non-pneumatic anti-shock garment (NASG): evidence from a cluster randomized controlled trial in Zambia and Zimbabwe

  Early application Later application Odds ratio (95% CI) p-value
Mortality 3/366 (0.8%) 12/466 (2.6%) 0.36 (0.08-1.53) 0.17
  Zimbabwe 1/166 (0.6%) 1/139 (0.7%)   
  Zambia 2/200 (1%) 11/327 (3.4%)   
Morbidity 0/363 (0.0%) 1/454 (0.2%)   
  Anemic at discharge 74/321 (23.1%) 68/322 (26.8%) 1.10 (0.61 – 1.99) 0.74
  Emergency hysterectomy 1/210 (0.4%) 0/295 (0.0%)   
  Time variables (mean minutes)     
  Study entry to death 282 391   
  Study entry to shock recoveryα 165 (90–279) 209 (114–386) 1.28 (1.05-1.57)β 0.015
  Study entry to exit 608.1 608.8   
  Study entry until NASG 2.4 144.1   
  1. αMedian (IQR); βHazard Ratio.